cp 65,526 has been researched along with su 11248 in 1 studies
Studies (cp 65,526) | Trials (cp 65,526) | Recent Studies (post-2010) (cp 65,526) | Studies (su 11248) | Trials (su 11248) | Recent Studies (post-2010) (su 11248) |
---|---|---|---|---|---|
65 | 1 | 5 | 4,338 | 560 | 3,200 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Katayama, K; Kawahara, H; Mitsuhashi, J; Noguchi, K; Sugimoto, Y | 1 |
1 other study(ies) available for cp 65,526 and su 11248
Article | Year |
---|---|
Pharmacological interaction with sunitinib is abolished by a germ-line mutation (1291T>C) of BCRP/ABCG2 gene.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Azides; Drug Resistance, Neoplasm; Estrone; Germ-Line Mutation; Humans; Indoles; K562 Cells; Mice; Neoplasm Proteins; Prazosin; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Vincristine | 2010 |